Pharmatest Announces New Customer Contracts Worth Nearly US$700.000 with Various Pharmaceutical Companies
Email Article
Print
10 May 2008
Pharmatest Services a full-service Contract Research Organization (CRO) announces today that it has signed new customer contracts valued at nearly US$700,000 during the first quarter of 2008 with multiple leading biopharmaceutical companies worldwide.
The new contracts include research projects in the therapeutic areas of oncology, women's health and inflammation (osteoarthritis). Services to be provided are preclinical lead validation and efficacy studies for new drug compounds.
